Current Liabilities
Boston Scientific·Balance Sheet Statement·8 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Total current liabilities | $5.6B | $5.9B | $6.4B | $5.1B | $5.2B | $5.3B | $5.4B | $4.6B |
| Other Commercial Liabilities | $2.3B | $2.5B | $2.8B | $2.4B | $2.8B | $3B | $3.2B | $2.5B |
| Accrued Liabilities, Current | $2.3B | $2.5B | $2.8B | $2.4B | $2.8B | $3B | $3.2B | $2.5B |
| Derivative Liabilities - Fair Value | $974M | $1.1B | $990M | $1B | $1.4B | $1.3B | $1.3B | $1.2B |
| Accounts payable | $906M | $907M | $960M | $1B | $962M | $1B | $1.1B | $1.1B |
| Other accrued liabilities | $770M | $891M | $887M | $923M | $952M | $862M | $795M | $875M |
| Supplier Finance Program Obligations | $131M | $137M | $140M | $129M | $139M | $151M | $144M | $145M |
| Finance Lease Liability, Current | — | — | — | — | — | — | $1M | — |